Shared genetics in coeliac disease and other immune-mediated diseases

Journal of Internal Medicine

Volumn 269, Issue 6, 2011, Pages 591-603

  Gutierrez Achury, J ^a   Coutinho de Almeida, R ^a,b   Wijmenga, C ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Autoimmune disease; Coeliac disease; Genetics; Risk factors

Indexed keywords

APILIMOD; INTERLEUKIN 23; TUMOR NECROSIS FACTOR INHIBITOR;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; CELIAC DISEASE; CONFERENCE PAPER; CROHN DISEASE; DISEASE COURSE; ENVIRONMENTAL FACTOR; FOLLOW UP; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLUTEN FREE DIET; HAPLOTYPE; HLA SYSTEM; HUMAN; INNATE IMMUNITY; MICROBIOME; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOIMMUNE DISEASES; CELIAC DISEASE; GENES, MHC CLASS II; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; RISK FACTORS;

EID: 79956288696     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02375.x     Document Type: Conference Paper

References (92)

1. Schuppan D, Junker Y, Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009; 137: 1912-33.
2. Book L, Zone JJ, Neuhausen SL. Prevalence of celiac disease among relatives of sib pairs with coeliac disease in U.S. families. Am J Gastroenterol 2003; 98: 377-81.
3. Nistico L, Fagnani C, Coto I et al. Concordance, disease progression, and heritability of celiac disease in Italian twins. Gut 2006; 55: 803-8.
4. Karell K, Louka AS, Moodie SJ et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003; 64: 469-77.
5. van Belzen MJ, Koeleman BP, Crusius JB et al. Defining the contribution of the HLA region to cisDQ2-positive coeliac disease patients. Genes Immun 2004; 5: 215-20.
6. Dubois PC, van Heel DA. Translational mini-review series on the immunogenetics of gut disease: immunogenetics of celiac disease. Clin Exp Immunol 2008; 153: 162-73.
7. Stene LC, Honeyman MC, Hoffenberg EJ et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006; 101: 2333-40.
8. Plot L, Amital H. Infectious associations of Celiac disease. Autoimmun Rev 2009; 8: 316-9.
9. Ivarsson A, Hernell O, Nystrom L, Persson LA. Children born in the summer have increased risk for coeliac disease. J Epidemiol Community Health 2003; 57: 36-'9.
10. Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child 2006; 91: 39-43.
11. Welander A, Tjernberg AR, Montgomery SM, Ludvigsson J, Ludvigsson JF. Infectious disease and risk of later celiac disease in childhood. Pediatrics 2010; 125: e530-6.
12. Pinier M, Fuhrmann G, Verdu E, Leroux JC. Prevention measures and exploratory pharmacological treatments of celiac disease. Am J Gastroenterol 2010; 105: 2551-61.
13. Di Sabatino A, Corazza GR. Coeliac disease. Lancet 2009; 373: 1480-93.
14. Lohi S, Mustalahti K, Kaukinen K et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther 2007; 26: 1217-25.
15. Oliveira RP, Sdepanian VL, Barreto JA et al. High prevalence of celiac disease in Brazilian blood donor volunteers based on screening by IgA antitissue transglutaminase antibody. Eur J Gastroenterol Hepatol 2007; 19: 43-9.
16. Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 2010; 7: 204-13.
17. Catassi C, Ratsch IM, Gandolfi L et al. Why is coeliac disease endemic in the people of the Sahara? Lancet 1999; 354: 647-8.
18. Godfrey JD, Brantner TL, Brinjikji W et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2010; 139: 763-9.
19. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009; 10: 43-55.
20. Dezsofi A, Szebeni B, Hermann CS et al. Frequencies of genetic polymorphisms of TLR4 and CD14 and of HLA-DQ genotypes in children with celiac disease, type 1 diabetes mellitus, or both. J Pediatr Gastroenterol Nutr 2008; 47: 283-7.
21. Laron Z, Lewy H, Wilderman I et al. Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in homogenous and heterogeneous populations. Isr Med Assoc J 2005; 7: 381-4.
22. Menconi F, Osman R, Monti MC, Greenberg DA, Concepcion ES, Tomer Y. Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Proc Natl Acad Sci U S A 2010; 107: 16899-903.
23. Alarida K, Harown J, Di Pierro MR, Drago S, Catassi C. HLA-DQ2 and -DQ8 genotypes in celiac and healthy Libyan children. Dig Liver Dis 2010; 42: 425-7.
24. Vincentini O, Maialetti F, Gazza L, Silano M, Dessi M, De Vincenzi M, Pogna NE. Environmental factors of celiac disease: cytotoxicity of hulled wheat species Triticum monococcum, T. turgidum ssp. dicoccum and T. aestivum ssp. spelta. J Gastroenterol Hepatol 2007; 22: 1816-22.
25. Silano M, Vincentini O, De Vincenzi M. Toxic, immunostimulatory and antagonist gluten peptides in celiac disease. Curr Med Chem 2009; 16: 1489-98.
26. Megiorni F, Mora B, Bonamico M et al. HLA-DQ and risk gradient for celiac disease. Hum Immunol 2009; 70: 55-9.
27. Romanos J, van Diemen CC, Nolte IM et al. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology 2009; 137: 834-40.
28. Tjon JM, van Bergen J, Koning F. Celiac disease: how complicated can it get? Immunogenetics 2010; 62: 641-51.
29. Bodd M, Raki M, Tollefsen S, Fallang LE, Bergseng E, Lundin KE, Sollid LM. HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol 2010; 3: 594-601.
30. Auger I, Sebbag M, Vincent C et al. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. Arthritis Rheum 2005; 52: 3424-32.
31. Erlich H, Valdes AM, Noble J et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008; 57: 1084-92.
32. Taneja V, David CS. Role of HLA class II genes in susceptibility/resistance to inflammatory arthritis: studies with humanized mice. Immunol Rev 2010; 233: 62-78.
33. Anderson CA, Massey DC, Barrett JC et al. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 2009; 136: 523-9.
34. Barker JM, Liu E. Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions. Adv Pediatr 2008; 55: 349-65.
35. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002; 2: 647-55.
36. Wolters VM, Wijmenga C. Genetic background of celiac disease and its clinical implications. Am J Gastroenterol 2008; 103: 190-5.
37. Greco L, Corazza G, Babron MC et al. Genome search in celiac disease. Am J Hum Genet 1998; 62: 669-75.
38. van Belzen MJ, Meijer JW, Sandkuijl LA et al. A major non-HLA locus in celiac disease maps to chromosome 19. Gastroenterology 2003; 125: 1032-41.
39. Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, Mougenot JF, Bach JF, Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to coeliac disease. Gut 1998; 43: 187-9.
40. Monsuur AJ, de Bakker PI, Alizadeh BZ et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005; 37: 1341-4.
41. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010; 363: 166-76.
42. International HapMap Consortium et al. A haplotype map of the human genome. Nature 2005; 437: 1299-320.
43. van Heel DA, Franke L, Hunt KA et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007; 39: 827-9.
44. Hunt KA, Zhernakova A, Turner G et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008; 40: 395-402.
45. Dubois PC, Trynka G, Franke L et al. Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 2010; 42: 295-302.
46. Trynka G, Wijmenga C, van Heel DA. A genetic perspective on coeliac disease. Trends Mol Med 2010; 16: 537-50.
47. Rubio-Tapia A, Murray JA. Celiac disease. Curr Opin Gastroenterol 2010; 26: 116-22.
48. Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Alaedini A, Yolken R. Markers of gluten sensitivity and celiac disease in bipolar disorder. Bipolar Disord 2011; 13: 52-8.
49. Pozzilli P, Strollo R, Barchetta I. Natural history and immunopathogenesis of type 1 diabetes. Endocrinol Nutr 2009; 56(Suppl 4): 50-2.
50. Molberg O, Sollid LM. A gut feeling for joint inflammation - using coeliac disease to understand rheumatoid arthritis. Trends Immunol 2006; 27: 188-94.
51. Simell S, Hoppu S, Simell T et al. Age at development of type 1 diabetes- and celiac disease-associated antibodies and clinical disease in genetically susceptible children observed from birth. Diabetes Care 2010; 33: 774-9.
52. Myasoedova E, Davis JM 3rd, Crowson CS, Gabriel SE. Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep 2010; 12: 379-85.
53. Schirbel A, Fiocchi C. Inflammatory bowel disease: established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis 2010; 11: 266-76.
54. Kakleas K, Karayianni C, Critselis E, Papathanasiou A, Petrou V, Fotinou A, Karavanaki K. The prevalence and risk factors for coeliac disease among children and adolescents with type 1 diabetes mellitus. Diabetes Res Clin Pract 2010; 90: 202-8.
55. Mahdi H, Fisher BA, Kallberg H et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009; 41: 1319-24.
56. McGovern DP, Gardet A, Torkvist L et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 2010; 42: 332-7.
57. Todd JA, Walker NM, Cooper JD et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39: 857-64.
58. Barrett JC, Clayton DG, Concannon P et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41: 703-7.
59. Stahl EA, Raychaudhuri S, Remmers EF et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010; 42: 508-14.
60. Zhernakova A, Elbers CC, Ferwerda B et al. Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet 2010; 86: 970-7.
61. Gregersen PK, Amos CI, Lee AT et al. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 2009; 41: 820-3.
62. Barrett JC, Hansoul S, Nicolae DL et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40: 955-62.
63. Doody KM, Bourdeau A, Tremblay ML. T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease. Immunol Rev 2009; 228: 325-41.
64. Faustman D, Davis M. TNF receptor 2 pathway: drug target for autoimmune diseases. Nat Rev Drug Discov 2010; 9: 482-93.
65. Wada Y, Lu R, Zhou D et al. Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor. Blood 2007; 109: 1156-64.
66. Shakoor N, Michalska M, Harris CA, Block JA. Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet 2002; 359: 579-80.
67. Cosnes J, Cellier C, Viola S et al. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol 2008; 6: 753-8.
68. Fuchtenbusch M, Ziegler AG, Hummel M. Elimination of dietary gluten and development of type 1 diabetes in high risk subjects. Rev Diabet Stud 2004; 1: 39-41.
69. Funda DP, Kaas A, Tlaskalova-Hogenova H, Buschard K. Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes. Diabetes Metab Res Rev 2008; 24: 59-63.
70. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity - friends or foes? Trends Immunol 2009; 30: 409-14.
71. Graham KL, Sanders N, Tan Y, Allison J, Kay TW, Coulson BS. Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J Virol 2008; 82: 6139-49.
72. Ruggeri C, La Masa AT, Rudi S et al. Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection. Dig Dis Sci 2008; 53: 2151-5.
73. Grunhage F, Nattermann J. Viral hepatitis: human genes that limit infection. Best Pract Res Clin Gastroenterol 2010; 24: 709-23.
74. Guarner F. Prebiotics, probiotics and helminths: the 'natural' solution? Dig Dis 2009; 27: 412-7.
75. Zhernakova A, Stahl E, Trynka G et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011; 7: e1002004.
76. Festen E, Goyette E, Green T et al. A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP and PUS10 as shared risk loci for Crohn's disease and celiac disease. PLoS Genet 2011; 7: e1001283.
77. Arnett FC et al. Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 2010; 69: 822-7.
78. Graham RR, Ortmann WA, Langefeld CD et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 2002; 71: 543-53.
79. Simmonds MJ, Howson JM, Heward JM et al. Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet 2005; 76: 157-63.
80. Bratanic N, Smigoc Schweiger D, Mendez A, Bratina N, Battelino T, Vidan-Jeras B. An influence of HLA-A, B, DR, DQ, and MICA on the occurrence of Celiac disease in patients with type 1 diabetes. Tissue Antigens 2010; 76: 208-15.
81. Radstake TR, Gorlova O, Rueda B et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 2010; 42: 426-9.
82. Barrett JC, Lee JC, Lees CW et al. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 2009; 41: 1330-4.
83. Franke A, McGovern DP, Barrett JC et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010; 42: 1118-25.
84. Reveille JD, Sims AM, Danoy P et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010; 42: 123-7.
85. De Jager PL, Jia X, Wang J et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009; 41: 776-82.
86. Graham RR, Cotsapas C, Davies L et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008; 40: 1059-61.
87. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 2009; 41: 824-8.
88. Imielinski M, Baldassano RN, Griffiths A et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 2009; 41: 1335-40.
89. Yang W, Shen N, Ye DQ et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 2010; 6: e1000841.
90. Logan I, Bowlus CL. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 2010; 9: A372-8.
91. Fujita PA, Rhead B, Zweig AS et al. The UCSC Genome Browser database: update 2011. Nucleic Acids Res 2010; 39: D876-82.
92. Raychaudhuri S, Plenge RM, Rossin EJ et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet 2009; 5: e1000534.